Drug Search Results
More Filters [+]

Fluspirilene

Alternative Names: fluspirilene, f-100, imap
Latest Update: 2023-02-23
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: D2 Antagonist,Calcium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Belgium | Canada | Germany | Ireland | Italy | Luxembourg | New Zealand | Peru | Portugal | Taiwan | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fluspirilene

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title